<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>While this study is larger than previous investigations and includes workers with a wide range of exposures to <z:chebi fb="56" ids="16716">benzene</z:chebi>, the estimates of risk, as measured by statistical confidence intervals, are still fairly broad, and would benefit from the larger numbers that could be provided by continued follow-up of this population </plain></SENT>
<SENT sid="1" pm="."><plain>Nevertheless, the study confirms earlier findings of increased risk for ANLL and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> among <z:chebi fb="56" ids="16716">benzene</z:chebi>-exposed workers, provides the first substantial evidence that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is linked to <z:chebi fb="56" ids="16716">benzene</z:chebi> exposure, and provides evidence that <z:chebi fb="56" ids="16716">benzene</z:chebi> increases risk for ANLL/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> at lower levels of exposure than had previously been demonstrated </plain></SENT>
<SENT sid="2" pm="."><plain>Currently we are evaluating the potential for extending the follow-up of workers included in this study </plain></SENT>
<SENT sid="3" pm="."><plain>A new study would include expanded data collection for cases of <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancy</z:e> and related disorders and for an appropriate control series </plain></SENT>
</text></document>